Primary diffuse large B-cell lymphoma of the bone: bendamustine and rituximab are able to overcome resistant disease

Primary bone lymphoma (PBL) is a rare disease for which specific therapeutic guidelines have not yet been established. Due to common appearance in the elderly and recurring relapses, new treatments are required. We report the case of multiple relapsed aggressive PBL effectively treated using Bendamu...

Descripción completa

Detalles Bibliográficos
Autores principales: Mondello, Patrizia, Mian, Michael, Arrigo, Carmela, Pitini, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Case Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101125/
https://www.ncbi.nlm.nih.gov/pubmed/25045615
http://dx.doi.org/10.1186/2193-1801-3-342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101125/
https://www.ncbi.nlm.nih.gov/pubmed/25045615
http://dx.doi.org/10.1186/2193-1801-3-342

Ejemplares similares